Rinderknecht, Emily https://orcid.org/0009-0002-7283-5237
Claps, Francesco
Bostrom, Peter J.
Shariat, Shahrokh F.
Neuzillet, Yann
Zlotta, Alexandre R.
Trombetta, Carlo
Eckstein, Markus
Lijnen, Renee A. G.
Mertens, Laura S.
Bussani, Rossana
Burger, Maximilian
van Leenders, Geert J. L. H.
Boormans, Joost L.
Wullich, Bernd
Hartmann, Arndt
Pavan, Nicola
Pouessel, Damien
van der Kwast, Theo H.
Allory, Yves
Zuiverloon, Tahlita C. M.
Lotan, Yair
van Rhijn, Bas W. G.
Mayr, Roman
Funding for this research was provided by:
Universität Regensburg
Article History
Received: 5 October 2025
Accepted: 8 November 2025
First Online: 20 November 2025
Declarations
:
: The authors have no financial or non-financial conflicts of interest to declare that are relevant to the content of this article.
: The study complies with the ethical standards described in the latest declaration of Helsinki; it was approved by the institutional ethics review board of the respective institutions. Site specific approval and protocol numbers: Amsterdam: The Institutional Review Board of the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital (CFMPB-160 & IRBd18126). Trieste: The University of Trieste Ethical Committee; Trieste (ID 113/2021). Regensburg: Medical ethical board of the University of Regensburg (16-101-0218). Paris: The regional ethics board of Ile-de-France IX – Comité de protection des personnes – Ile-de-France IX - Créteil (11-052). Toronto: The regional ethics board of the University Health Network, Toronto (02-0515-C, 08-0263-T, 09-0826-CE and 09-0556-TE). Turku: Ethical committee of the hospital district of South-West Finland, No: ETMK 6/2006. Erlangen: The ethical and translational boards, Erlangen (217_18 Bc and 329_16-B). Dallas: The Institutional Review Board for the Protection of Human Subjects at University of Texas Southwestern Medical School: STU 102014-008. Rotterdam: The medical-ethical board of Erasmus MC, Rotterdam (MEC 168.922/1998/55).